DIN 02560747 — EVRYSDI 5 MG
EVRYSDI is a tablet of Risdiplam marketed by HOFFMANN-LA ROCHE LIMITED. The full Risdiplam monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02560747
- Brand name
- EVRYSDI
- Active ingredient
- Risdiplam
- Strength
- 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- HOFFMANN-LA ROCHE LIMITED
- Health Canada status
- MARKETED
- Drug class
- Survival motor neuron 2 (SMN2) pre-mRNA splicing modifier
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Risdiplam products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02514931 | EVRYSDI | 0.75 MG | POWDER FOR SOLUTION | HOFFMANN-LA ROCHE LIMITED | MARKETED |